ArticleAnnals of surgical oncology2026
Early-Onset Appendiceal Adenocarcinoma (Age < 50 Years): Temporal Trends in Case Proportions, Histologic Patterns, and Survival Outcomes From SEER, 2000-2023.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAppendiceal adenocarcinoma is a rare gastrointestinal malignancy with rising incidence. The clinicopathologic features and outcomes of patients with a diagnosis before age 50 years (early-onset disease) have not been characterized in a large-scale contemporary national cohort.
methodsThe study identified 10,452 patients with appendiceal adenocarcinoma from the SEER Research Data, 17 Registries, 2000-2023. Patients were classified as early-onset (age < 50 years) or average-onset (age ≥ 50 years). Kaplan-Meier and multivariable Cox regression analyses were performed for overall survival (OS) and cancer-specific survival (CSS).
resultsAmong the 10,452 patients, 2219 (21.2%) were early-onset. The early-onset patients were more likely to be Hispanic (20% vs. 12%), to present with distant disease (52% vs. 46%), and to have mucinous histology (63% vs. 56%) (all p < 0.001). The proportion of early-onset cases declined from approximately 28% in 2000-2002 to 18% by 2022-2023 (slope-0.36% per year; p < 0.001). In multivariable analysis, average-onset age was independently associated with higher hazard of overall death (hazard ratio [HR] 1.55; 95% confidence interval [CI] 1.44-1.67) and cancer-specific death (HR 1.26; 95% CI 1.16-1.36). Non-Hispanic black patients had independently worse survival in both the full cohort (HR 1.16) and the early-onset subgroup (HR 1.35).
conclusionsEarly-onset appendiceal adenocarcinoma accounts for approximately one in five cases nationally and carries distinct demographic and histologic features. After adjustment, survival was shown to be driven primarily by stage and tumor characteristics rather than by age alone. Racial survival disparities in the early-onset population warrant further investigation.
Indexed as
Identifiers
42570985What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.